Veritone Under Investigation for Possible Securities Violations
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1 hour ago
0mins
Should l Buy VERI?
Source: Globenewswire
- Financial Results Disclosure: On March 26, 2026, Veritone filed an 8-K with the SEC, projecting fourth-quarter 2025 revenues between $18.1 million and $30 million, as it finalizes accounting determinations, resulting in a 30% stock price drop to $1.84.
- Financial Statement Revision: On April 14, 2026, Veritone announced that its previously issued financial statements should no longer be relied upon due to five categories of errors that collectively reduced quarterly revenue by $2.48 million (8.53%), causing an 8.3% decline in stock price to $2.09, highlighting issues with financial transparency.
- Legal Investigation Initiated: Kirby McInerney LLP is investigating potential violations of federal securities laws by Veritone and its senior management, with no lawsuits filed yet, indicating significant legal risks and a potential loss of investor confidence.
- Investor Rights Protection: The law firm is urging investors who purchased Veritone securities to provide information to discuss their rights and interests, indicating that the company's legal challenges may impact future investment decisions.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy VERI?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on VERI
Wall Street analysts forecast VERI stock price to rise
3 Analyst Rating
2 Buy
1 Hold
0 Sell
Moderate Buy
Current: 2.230
Low
6.00
Averages
8.33
High
10.00
Current: 2.230
Low
6.00
Averages
8.33
High
10.00
About VERI
Veritone, Inc. builds human-centered enterprise artificial intelligence (AI) solutions. Its AI operating system, aiWARE, uses machine learning algorithms, or AI models, together with a suite of applications, to reveal valuable insights from vast amounts of structured and unstructured data. Highly modular and customizable, aiWARE enables expansive scale with the flexibility to deploy in the cloud, at the edge or in hybrid environments. Its aiWARE platform offers capabilities that are designed to mimic human cognitive functions such as perception, prediction and problem solving, enabling users to transform unstructured data into structured data, and analyze and optimize data to drive business processes and insights. Its aiWARE platform encompasses industry applications, automate studio and developer APIs, intelligent data lake, applications and cognitive analytics, and generative AI. It serves customers in the media, entertainment, public sector and talent acquisition industries.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Veritone Under Investigation for Possible Securities Violations
- Financial Results Disclosure: On March 26, 2026, Veritone filed an 8-K with the SEC, projecting fourth-quarter 2025 revenues between $18.1 million and $30 million, as it finalizes accounting determinations, resulting in a 30% stock price drop to $1.84.
- Financial Statement Revision: On April 14, 2026, Veritone announced that its previously issued financial statements should no longer be relied upon due to five categories of errors that collectively reduced quarterly revenue by $2.48 million (8.53%), causing an 8.3% decline in stock price to $2.09, highlighting issues with financial transparency.
- Legal Investigation Initiated: Kirby McInerney LLP is investigating potential violations of federal securities laws by Veritone and its senior management, with no lawsuits filed yet, indicating significant legal risks and a potential loss of investor confidence.
- Investor Rights Protection: The law firm is urging investors who purchased Veritone securities to provide information to discuss their rights and interests, indicating that the company's legal challenges may impact future investment decisions.
See More
Veritone Faces Investor Lawsuit Investigation
- Legal Investigation Initiated: Bragar Eagel & Squire, P.C. is investigating Veritone, Inc. for potential violations of federal securities laws and other unlawful business practices, which may impact investor rights.
- Financial Reporting Issues: On April 14, 2026, Veritone disclosed to the SEC that its previously issued unaudited financial statements for the quarter ending September 30, 2025, contained five categories of errors, resulting in a revenue reduction of $2.48 million (8.53%), posing a threat to the company's financial health.
- Stock Price Decline Reaction: Following the disclosure of financial issues, Veritone's stock price fell by $0.19 (8.33%) to close at $2.09 per share on April 15, 2026, reflecting market concerns over the company's financial transparency.
- Investor Rights Protection: The law firm encourages all investors who purchased or held Veritone shares during this period to contact them to discuss potential legal options, aiming to protect their investment rights and seek compensation.
See More
Stock Futures Rise as Trump Delays Military Action Against Iran
- Unity Software Growth: Unity Software shares surged 15% after raising its Q1 revenue outlook to $505M-$508M, exceeding previous guidance of $480M-$490M, driven by strong performance in its Unity Vector offering, with Create revenue expected around $115M and Grow at $353M, while adjusted EBITDA is projected at $130M-$135M, indicating robust growth potential.
- Argan's Strong Performance: Argan shares rose 9% following a 13% year-over-year revenue increase in Q4, with both gross and EBITDA margins expanding by 450 basis points, and the company highlighted robust demand with $2.5B in new contracts added during the year, ending with a project backlog exceeding $2.9B, showcasing strong growth and profitability momentum.
- Zenas BioPharma Financing Plans: Zenas BioPharma shares fell 12% after announcing a dual capital raise, including $200M in 2.50% convertible senior notes and a 5M-share equity offering priced at $20 per share, with expected net proceeds of approximately $287.5M, indicating urgency in financing strategies as the notes mature in 2032.
- Veritone's Weak Preliminary Results: Veritone shares declined 8% after reporting preliminary Q4 revenue expectations of $18.1M-$30.0M, significantly below the $34.3M consensus, with preliminary GAAP net loss projected at $25.1M-$37.0M, reflecting financial pressures faced by the company.
See More
Veritone Reports Transformative Q4 2025 Earnings Insights
- Strategic Transaction Success: In Q4 2025, Veritone signed a complex multiparty nonmonetary transaction valued at $12.9 million, securing preferred access to over 50 million hours of monetizable data sets, with projected VDR revenue exceeding $100 million over three years, significantly enhancing the company's revenue potential and market competitiveness.
- Partnership with Oracle: The company established a multiyear strategic partnership with Oracle to deploy Veritone's aiWARE platform and data services on Oracle Cloud Infrastructure, marking a pivotal milestone that further solidifies Veritone's leadership in managing unstructured data.
- Financial Health Improvement: In Q4, Veritone fully retired its senior secured term debt and repurchased approximately 50% of its convertible notes, reducing annual debt carrying costs to $800,000 and closing the quarter with $27.7 million in cash and cash equivalents, indicating a significant improvement in the company's financial health.
- Optimistic Future Outlook: The CFO projected fiscal 2026 revenue between $130 million and $145 million, representing a 47% year-over-year increase, with public sector revenue expected to grow by 60% to 70%, indicating the company's intent to capture a larger share of the AI data economy.
See More
Veritone (VERI) Q4 2025 Earnings Call Transcript
See More
Veritone Announces Preliminary Q4 2025 Financial Results and Strategic Partnerships
- Financial Guidance: Veritone expects revenue for fiscal 2026 to range between $130 million and $145 million, representing a 47% year-over-year increase from the low end of 2025, indicating strong demand and growth potential in the AI market.
- Strategic Partnership: The multi-year strategic partnership with Oracle will accelerate the deployment of Veritone's aiWARE platform on Oracle Cloud Infrastructure, expected to significantly enhance the company's cloud computing efficiency and market competitiveness.
- Data Resource Expansion: Through transactions with new clients, Veritone has gained access to over 50 million hours of monetizable data sets, projected to generate over $100 million in VDR revenue over the next three years, further solidifying its leadership in the data market.
- Public Sector Growth: Veritone's public sector business is expected to grow between 60% to 70% year-over-year in 2026, driven by the expansion of existing federal contracts and new international deals, showcasing the company's strong execution in the government market.
See More
Veritone Under Investigation for Possible Securities Violations
- Financial Results Disclosure: On March 26, 2026, Veritone filed an 8-K with the SEC, projecting fourth-quarter 2025 revenues between $18.1 million and $30 million, as it finalizes accounting determinations, resulting in a 30% stock price drop to $1.84.
- Financial Statement Revision: On April 14, 2026, Veritone announced that its previously issued financial statements should no longer be relied upon due to five categories of errors that collectively reduced quarterly revenue by $2.48 million (8.53%), causing an 8.3% decline in stock price to $2.09, highlighting issues with financial transparency.
- Legal Investigation Initiated: Kirby McInerney LLP is investigating potential violations of federal securities laws by Veritone and its senior management, with no lawsuits filed yet, indicating significant legal risks and a potential loss of investor confidence.
- Investor Rights Protection: The law firm is urging investors who purchased Veritone securities to provide information to discuss their rights and interests, indicating that the company's legal challenges may impact future investment decisions.
See More
Veritone Faces Investor Lawsuit Investigation
- Legal Investigation Initiated: Bragar Eagel & Squire, P.C. is investigating Veritone, Inc. for potential violations of federal securities laws and other unlawful business practices, which may impact investor rights.
- Financial Reporting Issues: On April 14, 2026, Veritone disclosed to the SEC that its previously issued unaudited financial statements for the quarter ending September 30, 2025, contained five categories of errors, resulting in a revenue reduction of $2.48 million (8.53%), posing a threat to the company's financial health.
- Stock Price Decline Reaction: Following the disclosure of financial issues, Veritone's stock price fell by $0.19 (8.33%) to close at $2.09 per share on April 15, 2026, reflecting market concerns over the company's financial transparency.
- Investor Rights Protection: The law firm encourages all investors who purchased or held Veritone shares during this period to contact them to discuss potential legal options, aiming to protect their investment rights and seek compensation.
See More
Stock Futures Rise as Trump Delays Military Action Against Iran
- Unity Software Growth: Unity Software shares surged 15% after raising its Q1 revenue outlook to $505M-$508M, exceeding previous guidance of $480M-$490M, driven by strong performance in its Unity Vector offering, with Create revenue expected around $115M and Grow at $353M, while adjusted EBITDA is projected at $130M-$135M, indicating robust growth potential.
- Argan's Strong Performance: Argan shares rose 9% following a 13% year-over-year revenue increase in Q4, with both gross and EBITDA margins expanding by 450 basis points, and the company highlighted robust demand with $2.5B in new contracts added during the year, ending with a project backlog exceeding $2.9B, showcasing strong growth and profitability momentum.
- Zenas BioPharma Financing Plans: Zenas BioPharma shares fell 12% after announcing a dual capital raise, including $200M in 2.50% convertible senior notes and a 5M-share equity offering priced at $20 per share, with expected net proceeds of approximately $287.5M, indicating urgency in financing strategies as the notes mature in 2032.
- Veritone's Weak Preliminary Results: Veritone shares declined 8% after reporting preliminary Q4 revenue expectations of $18.1M-$30.0M, significantly below the $34.3M consensus, with preliminary GAAP net loss projected at $25.1M-$37.0M, reflecting financial pressures faced by the company.
See More
Veritone Reports Transformative Q4 2025 Earnings Insights
- Strategic Transaction Success: In Q4 2025, Veritone signed a complex multiparty nonmonetary transaction valued at $12.9 million, securing preferred access to over 50 million hours of monetizable data sets, with projected VDR revenue exceeding $100 million over three years, significantly enhancing the company's revenue potential and market competitiveness.
- Partnership with Oracle: The company established a multiyear strategic partnership with Oracle to deploy Veritone's aiWARE platform and data services on Oracle Cloud Infrastructure, marking a pivotal milestone that further solidifies Veritone's leadership in managing unstructured data.
- Financial Health Improvement: In Q4, Veritone fully retired its senior secured term debt and repurchased approximately 50% of its convertible notes, reducing annual debt carrying costs to $800,000 and closing the quarter with $27.7 million in cash and cash equivalents, indicating a significant improvement in the company's financial health.
- Optimistic Future Outlook: The CFO projected fiscal 2026 revenue between $130 million and $145 million, representing a 47% year-over-year increase, with public sector revenue expected to grow by 60% to 70%, indicating the company's intent to capture a larger share of the AI data economy.
See More
Veritone (VERI) Q4 2025 Earnings Call Transcript
See More
Veritone Announces Preliminary Q4 2025 Financial Results and Strategic Partnerships
- Financial Guidance: Veritone expects revenue for fiscal 2026 to range between $130 million and $145 million, representing a 47% year-over-year increase from the low end of 2025, indicating strong demand and growth potential in the AI market.
- Strategic Partnership: The multi-year strategic partnership with Oracle will accelerate the deployment of Veritone's aiWARE platform on Oracle Cloud Infrastructure, expected to significantly enhance the company's cloud computing efficiency and market competitiveness.
- Data Resource Expansion: Through transactions with new clients, Veritone has gained access to over 50 million hours of monetizable data sets, projected to generate over $100 million in VDR revenue over the next three years, further solidifying its leadership in the data market.
- Public Sector Growth: Veritone's public sector business is expected to grow between 60% to 70% year-over-year in 2026, driven by the expansion of existing federal contracts and new international deals, showcasing the company's strong execution in the government market.
See More
